Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
BMJ Open|August 8, 2018
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)Laura Ridolfi, Francesco de Rosa, Laura Fiammenghi, et al.Journal of Personalized Medicine|June 24, 2022
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical ApproachesGiacomo Miserocchi, Chiara Spadazzi, Sebastiano Calpona, et al.Journal of Experimental & Clinical Cancer Research : CR|January 16, 2014
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programmeMaresa Altomonte, Anna Di Giacomo, Paola Queirolo, et al.Frontiers in Immunology|October 26, 2019
Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" TumorsJenny Bulgarelli, Marcella Tazzari, Anna Maria Granato, et al.Journal of Chemotherapy (Florence, Italy)|January 31, 2018
The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian expertsErcole Concia, Claudio Viscoli, Valerio Del Bono, et al.Vaccines|July 27, 2022
Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer CenterElena Pancisi, Anna Maria Granato, Emanuela Scarpi, et al.Journal of Translational Medicine|July 24, 2014
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised "proof-of-principle" phase II studyFrancesco de Rosa, Laura Ridolfi, Ruggero Ridolfi, et al.Cancer Treatment Reviews|June 5, 2018
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitorsLuigia Stefania Stucci, Stella D'Oronzo, Marco Tucci, et al.Journal of Translational Medicine|June 4, 2013
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patientsLaura Ridolfi, Massimiliano Petrini, Anna Maria Granato, et al.European Journal of Cancer (Oxford, England : 1990)|November 8, 2022
Tumour infiltrating B cells discriminate checkpoint blockade-induced responsesSara Valpione, Luca G Campana, John Weightman, et al.Pageof 6